Evaluation of Functional Insulin Therapy in Type 1 Diabetic Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

December 31, 2014

Study Completion Date

November 30, 2015

Conditions
Type 1 Diabetes
Interventions
BEHAVIORAL

Education to Functional Insulin Therapy

"* Intake of Continuous Glucose Monitor for 5 to 7 days~* Functional Insulinotherapy training during 3 days, blood sampling, autoevaluation and QOL questionnary.~* 1 month after the training: Follow-up consultation, clinical exam, vital signs and data on diabetes~* 3 months after the training: Blood sampling, vital signs and data on diabetes~* 6 months after the training: 2 sessions of training, blood sampling, autoevaluation and QOL questionnary, vital signs and data on diabetes, Intake of Continuous Glucose Monitor for 5 to 7 days~* 9 months after the training: Blood sampling, vital signs and data on diabetes~* 1 to 3 weeks before last visit: Intake of Continuous Glucose Monitor for 5 to 7 days~* 12 months after the training: Follow-up consultation, clinical exam, vital signs and data on diabetes, autoevaluation and QOL questionnary"

Trial Locations (1)

34000

Montpellier University Hospital, Montpellier

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT01512680 - Evaluation of Functional Insulin Therapy in Type 1 Diabetic Patients | Biotech Hunter | Biotech Hunter